サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Irritable Bowel Syndrome Treatment Market Research Report – Global Forecast till 2023

過敏性腸症候群治療薬市場調査レポート‐2023年までの世界予測

レポート概要

世界の過敏性腸症候群治療薬市場:種類別(IBS-D, IBS-C and IBS-M)、薬剤の種類別(Lubiprostone、Linaclotide、Rifaximin、Eluxadoline、Alosetron)、エンドユーザー別(病院、クリニック、研究所)、地域別(米州、ヨーロッパ、アジア太平洋、中東&アフリカ(MEA))−2023年までの予測

市場スナップショット

世界の過敏性腸症候群(IBS)治療薬市場は2018年から2023年までに7.58%のCAGRで拡大が予想されます。IBSは生命を脅かすものではないものの、症状が長期に及び、患者がどのような生活を送るべきかということに大きな影響を与えます。IBSを発症することは精神的な影響を与え、うつに至ることがあります。その症状を放っておくことはできず、適切な治療を必要とします。過去数年間でIBSの罹患率は大幅に増加しています。そのため、世界的にIBSの治療薬の需要が加速しています。世界のIBS治療薬市場は2023年までに2,900ドルを超えると予想されます。この市場の成長を支える要因としては認知度の向上、医療費の増加、IBS治療のための強力な薬剤パイプラインが挙げられます。

レポート詳細

章ごとの価格

このレポートは章ごとの個別販売も行っております。
以下の章ごとの価格は予期せず変更となる可能性がありますので、お問い合わせ下さい。
$ 0の記載がある章をご希望の方も、お問い合わせ下さい。
※全てPDFでの販売となります。

Title Price
1 Report Prologue $ 1,350
2 Executive Summary $ 1,350
3 Market Introduction $ 0
4 Research Methodology $ 0
5 Market Dynamics $ 950
6 Market Factor Analysis $ 950
7 Global Irritable Bowel Syndrome Treatment Market by Type $ 1,650
8 Global Irritable Bowel Syndrome Treatment Market by Drug Type $ 1,650
9 Global Irritable Bowel Syndrome Treatment Market by End-user $ 1,650
10 Global Irritable Bowel Syndrome Treatment Market by Region $ 1,650
11 Competitive Landscape $ 1,050
12 Company Profiles $ 900
13 Appendix $ 0

目次

TABLE OF CONTENTS

1 Report Prologue

2 Executive Summary

3 Market Introduction
3.1 Definition 18
3.2 Scope of the Study 18
3.3 List of Assumptions 19
3.4 Market Structure 19

4 Research Methodology
4.1 Research Process 21
4.2 Primary Research 22
4.3 Secondary Research 23
4.4 Market Size Estimation 23
4.5 Forecast Model 24

5 Market Dynamics
5.1 Introduction 26
5.2 Drivers 27
5.2.1 Rising Prevalence of Anxiety 27
5.2.2 Strong Drug Pipeline 27
5.2.3 Increasing Prevalence of Depression 27
5.3 Restraints 28
5.3.1 Stringent Government Regulations 28
5.3.2 Limited Patient Satisfaction with IBS Treatment Provided by Healthcare Professionals 28
5.4 Opportunities 28
5.4.1 Increasing Reimbursement for IBS 28

6 Market Factor Analysis
6.1 Porter’s Five Forces Model 30
6.1.1 Bargaining Power of Suppliers 31
6.1.2 Bargaining Power of Buyers 31
6.1.3 Threat of New Entrants 31
6.1.5 Intense Rivalry 31
6.2 Value chain analysis 32
6.2.1 Research and Development 32
6.2.2 Manufacturing 32
6.2.3 Distribution & Sales 32
6.2.4 Post-Sales Monitoring 32

7 Global Irritable Bowel Syndrome Treatment Market by Type
7.1 Overview 34
7.2 IBS-D 35
7.3 IBS-C 35
7.4 IBS-M 36

8 Global Irritable Bowel Syndrome Treatment Market by Drug Type
8.1 Overview 38
8.2 Lubiprostone 39
8.3 Linaclotide 39
8.4 Eluxadoline 40
8.5 Rifaximin 40
8.6 Alosetron 41
8.7 Others 41

9 Global Irritable Bowel Syndrome Treatment Market by End-user
9.1 Overview 43
9.2 Hospitals 44
9.3 Clinics 44
9.4 Research Laboratories 45
9.5 Others 45

10 Global Irritable Bowel Syndrome Treatment Market by Region
10.1 Overview 47
10.2 Americas 49
10.2.1 North America 50
10.2.2 South America 54
10.3 Europe 56
10.3.1 Western Europe 57
10.3.2 Eastern Europe 65
10.4 Asia-Pacific 67
10.4.1 Japan 69
10.4.2 China 70
10.4.3 India 71
10.4.4 South Korea 72
10.4.5 Australia 73
10.4.6 Rest of Asia-Pacific 74
10.5 Middle East & Africa 75
10.5.1 Middle East 76
10.5.2 Africa 77

11 Competitive Landscape
11.2 Company Market Share Analysis 80

12 Company Profiles
12.1 Abbott 83
12.1.1 Company Overview 83
12.1.2 Financial Overview 83
12.1.3 Products Offering 84
12.1.4 SWOT Analysis 84
12.1.5 Key Developments 84
12.1.6 Key strategy 84
12.2 Allergan Inc. 85
12.2.1 Company Overview 85
12.2.2 Financial Overview 85
12.2.3 Products Offering 86
12.2.4 SWOT Analysis 86
12.2.5 Key Developments 86
12.2.6 Key strategy 86
12.3 Ardelyx, Inc. 87
12.3.1 Company Overview 87
12.3.2 Financial Overview 87
12.3.3 Products Offering 87
12.3.4 SWOT Analysis 87
12.3.5 Key Developments 88
12.3.6 Key Strategy 88
12.4 Astellas Pharma, Inc. 89
12.4.1 Company Overview 89
12.4.2 Financial Overview 89
12.4.3 Products Offering 89
12.4.4 SWOT Analysis 90
12.4.5 Key Developments 90
12.4.6 Key Strategy 90
12.5 Ironwood Pharmaceuticals 91
12.5.1 Company Overview 91
12.5.2 Company Overview 91
12.5.3 Products Offering 91
12.5.4 SWOT Analysis 92
12.5.5 Key Developments 92
12.5.6 Key strategy 92
12.6 Lexicon Pharmaceuticals, Inc. 93
12.6.1 Company Overview 93
12.6.2 Financial Overview 93
12.6.3 Products Offering 93
12.6.4 SWOT Analysis 93
12.6.5 Key Development 94
12.6.6 Key Strategy 94
12.7 Mallinckrodt 95
12.7.1 Company Overview 95
12.7.2 Financial Overview 95
12.7.3 Products Offering 95
12.7.4 SWOT Analysis 96
12.7.5 Key Developments 96
12.7.6 Key strategy 96
12.8 Nestle Health Science 97
12.8.1 Company Overview 97
12.8.2 Financial Overview 97
12.8.3 Products Offering 97
12.8.4 Key Developments 98
12.8.5 SWOT Analysis 98
12.8.6 Key Strategy 98
12.9 Synergy Pharmaceuticals Inc. 99
12.9.1 Company Overview 99
12.9.2 Financial Overview 99
12.9.3 Products Offering 99
12.9.4 Key Developments 99
12.9.5 SWOT Analysis 99
12.9.6 Key Strategy 99
12.10 Valeant Pharmaceuticals International, Inc. 100
12.10.1 Company Overview 100
12.10.2 Financial Overview 100
12.10.3 Products Offering 100
12.10.4 Key Developments 101
12.10.5 SWOT Analysis 101
12.10.6 Key Strategy 101

13 Appendix
13.1 Discussion Blue Print 103

14 List of Tables
TABLE 1 MARKET SYNOPSIS 16
TABLE 2 LIST OF ASSUMPTIONS 19
TABLE 3 PRIMARY INTERVIEWS 21
TABLE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET 30
TABLE 5 GLOBAL IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 34
TABLE 6 GLOBAL IBS TREATMENT MARKET FOR IBS-D BY REGION, 2015 TO 2023 (USD MILLION) 35
TABLE 7 GLOBAL IBS TREATMENT MARKET FOR IBS-C BY REGION, 2015 TO 2023 (USD MILLION) 35
TABLE 8 GLOBAL IBS TREATMENT MARKET FOR IBS-M BY REGION, 2015 TO 2023 (USD MILLION) 36
TABLE 9 GLOBAL IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 38
TABLE 10 GLOBAL IBS TREATMENT MARKET FOR LUBIPROSTONE BY REGION, 2015 TO 2023 (USD MILLION) 39
TABLE 11 GLOBAL IBS TREATMENT MARKET FOR LINACLOTIDE BY REGION, 2015 TO 2023 (USD MILLION) 39
TABLE 12 GLOBAL IBS TREATMENT MARKET FOR ELUXADOLINE BY REGION, 2015 TO 2023 (USD MILLION) 40
TABLE 13 GLOBAL IBS TREATMENT MARKET FOR RIFAXIMIN BY REGION, 2015 TO 2023 (USD MILLION) 40
TABLE 14 GLOBAL IBS TREATMENT MARKET FOR ALOSETRON BY REGION, 2015 TO 2023 (USD MILLION) 41
TABLE 15 GLOBAL IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 43
TABLE 16 GLOBAL IBS TREATMENT MARKET FOR HOSPITALS BY REGION, 2015 TO 2023 (USD MILLION) 44
TABLE 17 GLOBAL IBS TREATMENT MARKET FOR CLINICS BY REGION, 2015 TO 2023 (USD MILLION) 44
TABLE 18 GLOBAL IBS TREATMENT MARKET FOR RESEARCH LABORATORIES BY REGION, 2015 TO 2023 (USD MILLION) 45
TABLE 19 GLOBAL IBS TREATMENT MARKET BY REGION, 2015 TO 2023 (USD MILLION) 48
TABLE 20 AMERICAS IBS TREATMENT MARKET BY REGION, 2015 TO 2023 (USD MILLION) 49
TABLE 21 AMERICAS IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 49
TABLE 22 AMERICAS IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 50
TABLE 23 AMERICAS IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 50
TABLE 24 NORTH AMERICA IBS TREATMENT MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION) 51
TABLE 25 NORTH AMERICA IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 51
TABLE 26 NORTH AMERICA IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 51
TABLE 27 NORTH AMERICA IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 52
TABLE 28 US IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 52
TABLE 29 US IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 52
TABLE 30 US IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 53
TABLE 31 CANADA IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 53
TABLE 32 CANADA IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 53
TABLE 33 CANADA IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 54
TABLE 34 SOUTH AMERICA IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 54
TABLE 35 SOUTH AMERICA IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 54
TABLE 36 SOUTH AMERICA IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 55
TABLE 37 EUROPE IBS TREATMENT MARKET BY REGION, 2015 TO 2023 (USD MILLION) 56
TABLE 38 EUROPE IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 56
TABLE 39 EUROPE IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 57
TABLE 40 EUROPE IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 57
TABLE 41 WESTERN EUROPE IBS TREATMENT MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION) 58
TABLE 42 WESTERN EUROPE IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 58
TABLE 43 WESTERN EUROPE IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 58
TABLE 44 WESTERN EUROPE IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 59
TABLE 45 GERMANY IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 59
TABLE 46 GERMANY IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 59
TABLE 47 GERMANY IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 60
TABLE 48 FRANCE IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 60
TABLE 49 FRANCE IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 60
TABLE 50 FRANCE IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 61
TABLE 51 UK IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 61
TABLE 52 UK IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 61
TABLE 53 UK IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 62
TABLE 54 ITALY IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 62
TABLE 55 ITALY IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 62
TABLE 56 ITALY IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 63
TABLE 57 SPAIN IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 63
TABLE 58 SPAIN IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 63
TABLE 59 SPAIN IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 64
TABLE 60 REST OF WESTERN EUROPE IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 64
TABLE 61 REST OF WESTERN EUROPE IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 64
TABLE 62 REST OF WESTERN EUROPE IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 65
TABLE 63 EASTERN EUROPE IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 65
TABLE 64 EASTERN EUROPE IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 66
TABLE 65 EASTERN EUROPE IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 66
TABLE 66 ASIA-PACIFIC IBS TREATMENT MARKET BY COUNTRY, 2015 TO 2023 (USD MILLION) 67
TABLE 67 ASIA-PACIFIC IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 68
TABLE 68 ASIA-PACIFIC IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 68
TABLE 69 ASIA-PACIFIC IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 68
TABLE 70 JAPAN IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 69
TABLE 71 JAPAN IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 69
TABLE 72 JAPAN IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 69
TABLE 73 CHINA IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 70
TABLE 74 CHINA IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 70
TABLE 75 CHINA IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 70
TABLE 76 INDIA IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 71
TABLE 77 INDIA IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 71
TABLE 78 INDIA IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 71
TABLE 79 SOUTH KOREA IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 72
TABLE 80 SOUTH KOREA IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 72
TABLE 81 SOUTH KOREA IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 72
TABLE 82 AUSTRALIA IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 73
TABLE 83 AUSTRALIA IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 73
TABLE 84 AUSTRALIA IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 73
TABLE 85 REST OF ASIA-PACIFIC IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 74
TABLE 86 REST OF ASIA-PACIFIC IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 74
TABLE 87 REST OF ASIA-PACIFIC IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 74
TABLE 88 MIDDLE EAST & AFRICA IBS TREATMENT MARKET BY REGION, 2015 TO 2023 (USD MILLION) 75
TABLE 89 MIDDLE EAST & AFRICA IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 75
TABLE 90 MIDDLE EAST & AFRICA IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 76
TABLE 91 MIDDLE EAST & AFRICA IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 76
TABLE 92 MIDDLE EAST IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 76
TABLE 93 MIDDLE EAST IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 77
TABLE 94 MIDDLE EAST IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 77
TABLE 95 AFRICA IBS TREATMENT MARKET BY TYPE, 2015 TO 2023 (USD MILLION) 77
TABLE 96 AFRICA IBS TREATMENT MARKET BY DRUG TYPE, 2015 TO 2023 (USD MILLION) 78
TABLE 97 AFRICA IBS TREATMENT MARKET BY END-USER, 2015 TO 2023 (USD MILLION) 78

15 List of Figures
FIGURE 1 GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET: MARKET STRUCTURE 19
FIGURE 2 RESEARCH PROCESS 21
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 24
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET 26
FIGURE 5 SUPPLY CHAIN: GLOBAL IRRITABLE BOWEL SYNDROME TREATMENTMARKET 32
FIGURE 6 GLOBAL IBS TREATMENT MARKET BY TYPE, 2017 & 2023 (USD MILLION) 34
FIGURE 7 GLOBAL IBS TREATMENT MARKET BY DRUG TYPE, 2017 & 2023 (USD MILLION) 38
FIGURE 8 GLOBAL IBS TREATMENT MARKET BY END-USER, 2017 & 2023 (USD MILLION) 43
FIGURE 9 GLOBAL IBS TREATMENT MARKET BY REGION, 2017 (%) 47
FIGURE 10 GLOBAL IBS TREATMENT MARKET BY REGION, 2017 & 2023 (USD MILLION) 47
FIGURE 11 AMERICAS IBS TREATMENT MARKET BY REGION, 2017 (%) 49
FIGURE 12 NORTH AMERICA IBS TREATMENT MARKET BY COUNTRY, 2017 (%) 50
FIGURE 13 EUROPE IBS TREATMENT MARKET BY REGION, 2017 (%) 56
FIGURE 14 WESTERN EUROPE IBS TREATMENT MARKET BY COUNTRY, 2017 (%) 57
FIGURE 15 ASIA-PACIFIC IBS TREATMENT MARKET BY COUNTRY, 2017 (%) 67
FIGURE 16 MIDDLE EAST & AFRICA IBS TREATMENT MARKET BY REGION, 2017 (%) 75
FIGURE 17 GLOBAL IRRITABLE BOWEL SYNDROME TREATMENT MARKET, MARKET SHARE ANALYSIS, 2017 (%) 80

発刊日

2019/01

体裁

PDF / 105ページ

販売価格

4,450USD

発行

Market Research Future

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品原料・製剤 / 疾病別治療・領域別治療

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE